Corvus Pharmaceuticals
Rahul D. Pawar is a Sr. Scientist II at Corvus Pharmaceuticals. With a Ph.D. in Human Biology focusing on autoimmunity, lupus nephritis, and toll-like receptors, Rahul has extensive experience in autoimmune disease research. Starting from Ranbaxy Research Laboratories to prestigious research institutes like Albert Einstein College of Medicine and Stanford University, Rahul has worked on various aspects of autoimmunity, immunology, and drug development. Their current role involves evaluating the immunomodulatory effects of novel drug candidates in T Cell Lymphoma and developing primary cell-based assays for molecular mechanism identification.
This person is not in any offices
Corvus Pharmaceuticals
2 followers
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.